Bill > S3134

This bill expands the Fentanyl Sanctions Act to address a broader range of drug trafficking issues by introducing new definitions and modifying existing provisions. It defines two new terms: "copy-cat ingredient" (a substance designed to mimic an approved pharmaceutical but manufactured differently or with lower quality) and clarifies the existing definition of "counterfeit drug". The bill broadens the scope of the Act from focusing solely on opioids to addressing "illicit drugs" more comprehensively, which allows for wider application of sanctions and intelligence resources. It also provides the Director of National Intelligence more flexibility by allowing delegation of certain responsibilities and modifies requirements for identifying foreign drug traffickers. Additionally, the bill includes a waiver provision for accessing prescription medications that are currently on a drug shortage list maintained by the Department of Health and Human Services. The technical amendments throughout the bill replace references to "opioids" with "illicit drugs", effectively expanding the legislative framework to combat a wider range of pharmaceutical trafficking and counterfeiting activities.

Housing and Urban Affairs

https://www.congress.gov/bill/119th-congress/senate-bill/3134/all-info